While respiratory syncytial virus and the flu may have peaked, hospitals are still seeing high numbers of ill patients, and there is no telling whether holiday gatherings will reverse the plateau, CNN reported Dec. 21.
The Joint Commission is undergoing sweeping overhaul of its standards, eliminating 168 standards (14 percent) and revising another 14 standards. The commission is looking to make its accreditation programs as “efficient and impactful on patient safety,…
Health system leaders are expecting healthcare decisions in 2023 to be defined by staffing challenges, inflation, patient affordability, shrinking margins and supply chain struggles, according to a recent Deloitte Center for Health Solutions survey.
James Reed, MD, president and CEO of Albany, N.Y.-based St. Peter’s Health Partners and Syracuse, N.Y.-based St. Joseph’s Health, will retire December 31.
As drugmakers prepare for the government to stop paying for their COVID-19 treatments, the value of Pfizer’s popular COVID-19 drug Paxlovid has decreased by more than 80 percent, according to the Institute for Clinical and Economic Review.
Not only do healthcare companies, including hospital groups, face sustained challenges related to labor shortages and inflation into 2023, they are up against a wall of maturing debt looming large in 2024 and 2025, analysts at Moody’s said.